These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33510844)

  • 1. Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD).
    Drygalski K; Siewko K; Chomentowski A; Odrzygóźdź C; Zalewska A; Krętowski A; Maciejczyk M
    Oxid Med Cell Longev; 2021; 2021():8872702. PubMed ID: 33510844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
    Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
    Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease.
    Jorgačević B; Vučević D; Samardžić J; Mladenović D; Vesković M; Vukićević D; Ješić R; Radosavljević T
    Curr Med Chem; 2021; 28(1):169-180. PubMed ID: 32124686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).
    Grattagliano I; Di Ciaula A; Baj J; Molina-Molina E; Shanmugam H; Garruti G; Wang DQ; Portincasa P
    Methods Mol Biol; 2021; 2310():201-246. PubMed ID: 34096005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model.
    Tamura YO; Sugama J; Iwasaki S; Sasaki M; Yasuno H; Aoyama K; Watanabe M; Erion DM; Yashiro H
    J Pharmacol Exp Ther; 2021 Nov; 379(3):280-289. PubMed ID: 34535562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway.
    Meng D; Yin G; Chen S; Zhang X; Yu W; Wang L; Liu H; Jiang W; Sun Y; Zhang F
    Eur J Pharmacol; 2024 Aug; 977():176737. PubMed ID: 38866362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
    Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
    Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
    PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.
    Li Z; Zhang H; Li Y; Chen H; Wang C; Wong VKW; Jiang Z; Zhang W
    Phytomedicine; 2020 Apr; 69():153209. PubMed ID: 32240928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
    Liu W; Baker SS; Baker RD; Zhu L
    Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose.
    Drygalski K; Fereniec E; Zalewska A; Krętowski A; Żendzian-Piotrowska M; Maciejczyk M
    Biomed Pharmacother; 2021 Oct; 142():111958. PubMed ID: 34333287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
    Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T
    Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases.
    Ezhilarasan D; Lakshmi T
    Oxid Med Cell Longev; 2022; 2022():9233650. PubMed ID: 35602098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
    BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.